Pharma future & health

Business

Deal & Finance

Roche takes aim at inflammatory bowel disease

With its oncology drugs in decline and a string of recent failures on Alzheimer's, the Swiss giant veers into Inflammatory Bowel Diseases (IBD) by securing for more than 7 billion the U.S. rights to an investigational new drug.

Sanofi’s strategic turnaround

Goodbye NASH, it’s Alfasigma’s time

Agreement for antiviral biologics low cost production

Baxter and Hillrom: advancing healthcare together

Highly potent API expansion for Olon Rodano site

BIODRUGS & ATMP

BioDrugs & ATMP

62° AFI Symposium – Maria Luisa Nolli’s interview

The 62° AFI National Symposium opens with an initial session devoted to the evolution of advanced therapies for safer, more effective and accessible drugs for patients.

ONE HEALTH

Clinical research

DARWIN EU: towards easy and secure access to health data

Redazione -
DARWIN EU, acronym for Data Analysis and Real World Interrogation Network, is the new long-term project of EMA, the European Medicines Agency. The objective...

Novel foods that divide

Seguici sui social

16,985FansLike
2,458FollowersFollow
61,453SubscribersSubscribe
spot_img
spot_img
spot_img
spot_img
spot_img
spot_img
© Newspaper WordPress Theme by TagDiv